Report 5 figures and tables: Economic Burden of Illness in Canada, 2005–2008

Report 5: EBIC Value of Lost Production due to Morbidity, 2005-2010

Figures and Tables

Table 15: Value of Lost Production due to Morbidity by Diagnostic Category and Selected Demographic Group, Canada, 2010
($' 000,000 Current Dollars)
Diagnostic Category	Male Cost		Female Cost		Age 15-54 years Cost		Age 55-75 years Cost		Total Cost
Certain Infectious and Parasitic Diseases	423.6		436.2		750.1		109.7	^{Table 15 - Footnote *}	859.8
Respiratory Infections	1,555.0		1,349.0		2,530.8		373.2		2,904.0
Malignant Neoplasms	402.7	^{Table 15 - Footnote **}	126.3	^{Table 15 - Footnote *}	300.6	^{Table 15 - Footnote **}	228.4	^{Table 15 - Footnote *}	529.1	^{Table 15 - Footnote *}
Diabetes Mellitus	140.6	^{Table 15 - Footnote **}	18.1	^{Table 15 - Footnote **}	53.5	^{Table 15 - Footnote *}	105.2	^{Table 15 - Footnote **}	158.6	^{Table 15 - Footnote *}
Neuropsychiatric Conditions	623.5		625.8		1,118.9		130.4	^{Table 15 - Footnote *}	1,249.3
Cardiovascular Diseases	226.5	^{Table 15 - Footnote *}	74.3	^{Table 15 - Footnote *}	205.9	^{Table 15 - Footnote **}	94.9	^{Table 15 - Footnote *}	300.8	^{Table 15 - Footnote *}
Respiratory Diseases	66.1	^{Table 15 - Footnote *}	51.6	^{Table 15 - Footnote *}	78.9	^{Table 15 - Footnote *}	38.7	^{Table 15 - Footnote *}	117.6
Digestive Diseases	120.2	^{Table 15 - Footnote *}	49.2	^{Table 15 - Footnote *}	102.1	^{Table 15 - Footnote *}	67.4	^{Table 15 - Footnote **}	169.5	^{Table 15 - Footnote *}
Genitourinary Diseases	180.2	^{Table 15 - Footnote **}	40.4	^{Table 15 - Footnote **}	209.7	^{Table 15 - Footnote **}	10.9	^{Table 15 - Footnote **}	220.6	^{Table 15 - Footnote *}
Musculoskeletal Diseases	764.3		761.3		1,248.6		277.1		1,525.6
Injuries	2,281.4		942.8		2,468.3		755.9		3,224.2
Unattributable	2,969.8		3,935.2		5,788.8		1,116.2		6,905.0
Total	9,753.8		8,410.3		14,856.2		3,307.8		18,164.1
Footnote * High sampling variability Footnote * *Very high sampling variability Note: Any discrepancies may be due to rounding.*

Table 16: Value of Lost Production due to Morbidity by Diagnostic Category and Selected Demographic Group, Canada, 2009
($' 000,000 Current Dollars)
Diagnostic Category	Male Cost		Female Cost		Age 15-54 years Cost		Age 55-75 years Cost		Total Cost
Certain Infectious and Parasitic Diseases	406.9		421.1		726.6		101.3	^{Table 16 - Footnote *}	827.9
Respiratory Infections	1,494.3		1,322.0		2,464.0		352.3		2,816.3
Malignant Neoplasms	358.2	^{Table 16 - Footnote **}	111.4	^{Table 16 - Footnote *}	274.8	^{Table 16 - Footnote **}	194.8	^{Table 16 - Footnote *}	469.6	^{Table 16 - Footnote *}
Diabetes Mellitus	120.9	^{Table 16 - Footnote **}	17.5	^{Table 16 - Footnote **}	51.5	^{Table 16 - Footnote *}	86.9	^{Table 16 - Footnote **}	138.4	^{Table 16 - Footnote *}
Neuropsychiatric Conditions	549.4		568.4		1,003.8		114.1	^{Table 16 - Footnote *}	1,117.9
Cardiovascular Diseases	205.2	^{Table 16 - Footnote *}	68.8	^{Table 16 - Footnote *}	189.1	^{Table 16 - Footnote **}	84.9	^{Table 16 - Footnote *}	274.1	^{Table 16 - Footnote *}
Respiratory Diseases	61.7	^{Table 16 - Footnote *}	50.2	^{Table 16 - Footnote *}	77.2	^{Table 16 - Footnote *}	34.7	^{Table 16 - Footnote *}	111.8
Digestive Diseases	107.7	^{Table 16 - Footnote *}	47.4	^{Table 16 - Footnote *}	99.2	^{Table 16 - Footnote *}	55.8	^{Table 16 - Footnote **}	155.1	^{Table 16 - Footnote *}
Genitourinary Diseases	141.1	^{Table 16 - Footnote **}	32.7	^{Table 16 - Footnote **}	163.8	^{Table 16 - Footnote **}	10.0	^{Table 16 - Footnote **}	173.8	^{Table 16 - Footnote *}
Musculoskeletal Diseases	713.0		720.4		1,184.0		249.4		1,433.4
Injuries	2,105.0		887.5		2,313.1		679.4		2,992.5
Unattributable	2,740.5		3,702.3		5,420.6		1,022.2		6,442.8
Total	9,003.8		7,949.7		13,967.8		2,985.8		16,953.6
Footnote * High sampling variability Footnote * *Very high sampling variability Note: Any discrepancies may be due to rounding.*

Table 17: Value of Lost Production due to Morbidity by Diagnostic Category and Selected Demographic Group, Canada, 2008
($' 000,000 Current Dollars)
Diagnostic Category	Male Cost		Female Cost		Age 15-54 years Cost		Age 55-75 years Cost		Total Cost
Certain Infectious and Parasitic Diseases	418.6		408.3		732.3		94.6	^{Table 17 - Footnote *}	826.9
Respiratory Infections	1,537.7		1,274.8		2,483.4		329.0		2,812.4
Malignant Neoplasms	325.2	^{Table 17 - Footnote **}	94.8	^{Table 17 - Footnote *}	248.6	^{Table 17 - Footnote **}	171.4	^{Table 17 - Footnote *}	420.0	^{Table 17 - Footnote *}
Diabetes Mellitus	116.1	^{Table 17 - Footnote **}	16.8	^{Table 17 - Footnote **}	51.7	^{Table 17 - Footnote *}	81.2	^{Table 17 - Footnote **}	132.9	^{Table 17 - Footnote *}
Neuropsychiatric Conditions	511.8		512.5		927.9		96.5	^{Table 17 - Footnote *}	1,024.4
Cardiovascular Diseases	206.3	^{Table 17 - Footnote *}	63.3	^{Table 17 - Footnote *}	194.1	^{Table 17 - Footnote **}	75.5	^{Table 17 - Footnote *}	269.6	^{Table 17 - Footnote *}
Respiratory Diseases	61.6	^{Table 17 - Footnote *}	48.4	^{Table 17 - Footnote *}	76.8	^{Table 17 - Footnote *}	33.2	^{Table 17 - Footnote *}	110.0
Digestive Diseases	105.6	^{Table 17 - Footnote *}	45.5	^{Table 17 - Footnote *}	98.6	^{Table 17 - Footnote *}	52.5	^{Table 17 - Footnote **}	151.1	^{Table 17 - Footnote *}
Genitourinary Diseases	129.3	^{Table 17 - Footnote **}	27.3	^{Table 17 - Footnote **}	145.1	^{Table 17 - Footnote **}	11.5	^{Table 17 - Footnote **}	156.5	^{Table 17 - Footnote *}
Musculoskeletal Diseases	713.0		682.5		1,177.3		218.2		1,395.5
Injuries	2,081.7		827.3		2,290.8		618.2		2,909.0
Unattributable	2,715.6		3,472.4		5,257.2		930.9		6,188.1
Total	8,922.5		7,473.9		13,683.8		2,712.6		16,396.4
Footnote * High sampling variability Footnote * *Very high sampling variability Note: Any discrepancies may be due to rounding.*

Table 18: Value of Lost Production due to Morbidity by Diagnostic Category and Selected Demographic Group, Canada, 2007
($' 000,000 Current Dollars)
Diagnostic Category	Male Cost		Female Cost		Age 15-54 years Cost		Age 55-75 years Cost		Total Cost
Certain Infectious and Parasitic Diseases	389.4		388.2		692.7		85.0	^{Table 18 - Footnote *}	777.6
Respiratory Infections	1,422.8		1,215.5		2,338.8		299.5		2,638.3
Malignant Neoplasms	331.7	^{Table 18 - Footnote **}	89.5	^{Table 18 - Footnote *}	254.7	^{Table 18 - Footnote **}	166.5	^{Table 18 - Footnote *}	421.2	^{Table 18 - Footnote *}
Diabetes Mellitus	117.4	^{Table 18 - Footnote **}	16.2	^{Table 18 - Footnote **}	48.9	^{Table 18 - Footnote *}	84.7	^{Table 18 - Footnote **}	133.6	^{Table 18 - Footnote *}
Neuropsychiatric Conditions	487.0		493.5		891.9		88.6	^{Table 18 - Footnote *}	980.5
Cardiovascular Diseases	197.4	^{Table 18 - Footnote *}	58.7	^{Table 18 - Footnote *}	188.6	^{Table 18 - Footnote **}	67.5	^{Table 18 - Footnote *}	256.2	^{Table 18 - Footnote *}
Respiratory Diseases	58.0	^{Table 18 - Footnote *}	46.3	^{Table 18 - Footnote *}	73.5	^{Table 18 - Footnote *}	30.8	^{Table 18 - Footnote *}	104.3
Digestive Diseases	104.5	^{Table 18 - Footnote *}	44.4	^{Table 18 - Footnote *}	94.0	^{Table 18 - Footnote *}	54.9	^{Table 18 - Footnote **}	148.9	^{Table 18 - Footnote *}
Genitourinary Diseases	125.8	^{Table 18 - Footnote **}	26.8	^{Table 18 - Footnote **}	143.8	^{Table 18 - Footnote **}	8.8	^{Table 18 - Footnote **}	152.7	^{Table 18 - Footnote *}
Musculoskeletal Diseases	677.4		644.1		1,117.0		204.5		1,321.5
Injuries	1,950.3		797.7		2,160.9		587.0		2,748.0
Unattributable	2,570.5		3,359.4		5,074.6		855.4		5,930.0
Total	8,432.4		7,180.4		13,079.3		2,533.4		15,612.7
Footnote * High sampling variability Footnote * *Very high sampling variability Note: Any discrepancies may be due to rounding.*

Table 19: Value of Lost Production due to Morbidity by Diagnostic Category and Selected Demographic Group, Canada, 2006
($' 000,000 Current Dollars)
Diagnostic Category	Male Cost		Female Cost		Age 15-54 years Cost		Age 55-75 years Cost		Total Cost
Certain Infectious and Parasitic Diseases	372.6		366.7		659.9		79.4	^{Table 19 - Footnote *}	739.3
Respiratory Infections	1,354.3		1,143.4		2,216.2		281.5		2,497.7
Malignant Neoplasms	323.5	^{Table 19 - Footnote **}	87.4	^{Table 19 - Footnote *}	249.3	^{Table 19 - Footnote **}	161.6	^{Table 19 - Footnote *}	410.9	^{Table 19 - Footnote *}
Diabetes Mellitus	114.8	^{Table 19 - Footnote **}	15.5	^{Table 19 - Footnote **}	47.0	^{Table 19 - Footnote *}	83.3	^{Table 19 - Footnote **}	130.3	^{Table 19 - Footnote *}
Neuropsychiatric Conditions	486.7		482.7		883.8		85.7	^{Table 19 - Footnote *}	969.5
Cardiovascular Diseases	184.4	^{Table 19 - Footnote *}	56.5	^{Table 19 - Footnote *}	176.0	^{Table 19 - Footnote **}	64.9	^{Table 19 - Footnote *}	240.9	^{Table 19 - Footnote *}
Respiratory Diseases	52.5	^{Table 19 - Footnote *}	43.5	^{Table 19 - Footnote *}	67.9	^{Table 19 - Footnote *}	28.1	^{Table 19 - Footnote *}	96.0
Digestive Diseases	99.6	^{Table 19 - Footnote *}	42.3	^{Table 19 - Footnote *}	87.5	^{Table 19 - Footnote *}	54.4	^{Table 19 - Footnote **}	141.9	^{Table 19 - Footnote *}
Genitourinary Diseases	123.1	^{Table 19 - Footnote **}	27.4	^{Table 19 - Footnote **}	142.8	^{Table 19 - Footnote **}	7.6	^{Table 19 - Footnote **}	150.5	^{Table 19 - Footnote *}
Musculoskeletal Diseases	656.5		607.4		1,060.0		203.9		1,263.9
Injuries	1,902.9		757.0		2,085.6		574.2		2,659.8
Unattributable	2,490.8		3,218.6		4,902.6		806.7		5,709.4
Total	8,161.6		6,848.4		12,578.5		2,431.5		15,010.0
Footnote * High sampling variability Footnote * *Very high sampling variability Note: Any discrepancies may be due to rounding.*

Table 20: Value of Lost Production due to Morbidity by Diagnostic Category and Selected Demographic Group, Canada, 2005
($' 000,000 Current Dollars)
Diagnostic Category	Male Cost		Female Cost		Age 15-54 years Cost		Age 55-75 years Cost		Total Cost
Certain Infectious and Parasitic Diseases	359.5		352.8		638.8		73.6	^{Table 20 - Footnote *}	712.4
Respiratory Infections	1,304.7		1,096.7		2,141.5		259.9		2,401.4
Malignant Neoplasms	307.8	^{Table 20 - Footnote **}	86.9	^{Table 20 - Footnote *}	245.1	^{Table 20 - Footnote **}	149.6	^{Table 20 - Footnote *}	394.7	^{Table 20 - Footnote *}
Diabetes Mellitus	106.5	^{Table 20 - Footnote **}	15.8	^{Table 20 - Footnote **}	45.7	^{Table 20 - Footnote *}	76.7	^{Table 20 - Footnote **}	122.3	^{Table 20 - Footnote *}
Neuropsychiatric Conditions	488.8		466.2		868.6		86.4	^{Table 20 - Footnote *}	955.0
Cardiovascular Diseases	181.1	^{Table 20 - Footnote *}	53.4	^{Table 20 - Footnote *}	175.5	^{Table 20 - Footnote **}	59.0	^{Table 20 - Footnote *}	234.5	^{Table 20 - Footnote *}
Respiratory Diseases	51.5	^{Table 20 - Footnote *}	41.2	^{Table 20 - Footnote *}	65.3	^{Table 20 - Footnote *}	27.4	^{Table 20 - Footnote *}	92.7
Digestive Diseases	94.4	^{Table 20 - Footnote *}	39.2	^{Table 20 - Footnote *}	83.6	^{Table 20 - Footnote *}	50.0	^{Table 20 - Footnote **}	133.6	^{Table 20 - Footnote *}
Genitourinary Diseases	128.6	^{Table 20 - Footnote **}	31.2	^{Table 20 - Footnote **}	151.9	^{Table 20 - Footnote **}	7.9	^{Table 20 - Footnote **}	159.8	^{Table 20 - Footnote *}
Musculoskeletal Diseases	631.0		579.2		1,021.1		189.1		1,210.2
Injuries	1,833.1		720.2		2,026.8		526.5		2,553.3
Unattributable	2,418.4		3,087.0		4,746.0		759.4		5,505.3
Total	7,905.5		6,569.8		12,209.8		2,265.4		14,475.2
Footnote * High sampling variability Footnote * *Very high sampling variability Note: Any discrepancies may be due to rounding.*

Table 21: Value of Lost Production due to Morbidity by Age Group, Canada, 2005-2010
($' 000,000 Current Dollars)
Age Group	2010	% of Total Cost	2009	% of Total Cost	2008	% of Total Cost	2007	% of Total Cost	2006	% of Total Cost	2005	% of Total Cost
15-34 years	4,135.7	23	3,846.1	23	3,771.2	23	3,485.8	22	3,377.2	22	3,250.4	22
35-54 years	10,720.5	59	10,121.6	60	9,912.5	60	9,593.6	61	9,201.2	61	8,959.4	62
55-64 years	3,107.4	17	2,809.1	17	2,546.2	16	2,382.6	15	2,301.2	15	2,139.1	15
65-75 years	200.4	1	176.7	1	166.4	1	150.8	1	130.3	1	126.3	1
Total Cost	18,164.1	100	16,953.6	100	16,396.4	100	15,612.7	100	15,010.0	100	14,475.2	100

Table 22: Value of Lost Production due to Morbidity, Canada, 2005-2010
($'000,000 2010 Constant Dollars)
Year	Total Morbidity Cost
2010	18,164.1
2009	17,264.8
2008	16,741.3
2007	16,312.9
2006	16,028.0
2005	15,760.4

Appendix 1: Mapping of CCHS Disease Categories to EBIC Diagnostic Categories

Infectious and Parasitic Diseases
- Own Infectious Disease (lop_020)
- Stomach Flu (lop_084)
- Other Infectious Disease (lop_086)
Respiratory Infections
- Cold (lop_082)
- Flu or Influenza (lop_083)
- Respiratory Infection (lop_085)
Malignant Neoplasms
- Cancer (lop_050)
Diabetes Mellitus
- Diabetes (lop_050)
Neuropsychiatric Conditions
- Migraine (lop_050)
- Mental Illness (lop_050)
- Neurological Disease (lop_050)
Cardiovascular Diseases
- Cardiovascular Disease (lop_050)
Respiratory Diseases
- Asthma (lop_050)
- Chronic Bronchitis, Emphysema and Chronic Obstructive Pulmonary Disease (COPD) (lop_050)
Digestive Diseases
- Digestive Diseases (lop_050)
Genitourinary Diseases
- Kidney Disease (lop_050)
Musculoskeletal Diseases
- Arthritis (lop_050)
- Osteoporosis (lop_050)
- Back Problems (lop_050)
- Fibromyalgia, Chronic Fatigue Syndrome or Multiple Chemical Sensitivities (lop_050)
Injuries
- Own Injury (lop_020)
- Injury (lop_070)
Unattributable
- Other (lop_050)
- Don't Know (lop_050)
- Refusal (lop_050)
- Not Stated (lop_050)
- Other Reason Related to Physical or Mental Health (lop_020)
- Other Reason Related to Physical or Mental Health (lop_100)

Note: The text in the bracket indicates the 2010 CCHS LOP module question (65).

Appendix 2: Sampling Variability Guidelines

Type of Estimate	Coefficient of variation (CV) in %	Guidelines
Acceptable: moderate sampling variability	0.0 ≤ CV ≤ 16.5	Estimates can be considered for general unrestricted release.
Marginal: high sampling variability	16.6 ≤ CV ≤ 33.3	Estimates can be considered for general unrestricted release but should be accompanied by a warning cautioning subsequent users of high sampling variability associated with the estimates.
Unacceptable: very high sampling variability	CV > 33.3	Statistics Canada recommends not releasing estimates of unacceptable quality. The user is advised that these EBIC morbidity cost estimates do not meet Statistics Canada's quality standards for this statistical program. Conclusions based on these data will be unreliable and most likely invalid. These data and any consequent findings should not be published. If the user chooses to publish these data or findings, then this disclaimer must be published with the data.
Source: Statistics Canada (64)

Page details

Date modified:: 2014-06-20

Language selection

Search

Report 5 figures and tables: Economic Burden of Illness in Canada, 2005–2008

Report 5: EBIC Value of Lost Production due to Morbidity, 2005-2010

Figures and Tables

Appendix 1: Mapping of CCHS Disease Categories to EBIC Diagnostic Categories

Appendix 2: Sampling Variability Guidelines

Page details